News on Medial

Related News

Go Zero secures Rs 30 Cr in Series A round

EntrackrEntrackr · 9m ago
Go Zero secures Rs 30 Cr in Series A round
Medial

Snippets Go Zero secures Rs 30 Cr in Series A round Ice cream brand Go Zero has raised Rs 30 crore (around $3.4 million) in its Series A funding round from existing investors DSG Consumer Partners, Saama Capital, and V3 Ventures Ice cream brand Go Zero has raised Rs 30 crore (around $3.4 million) in its Series A funding round from existing investors DSG Consumer Partners, Saama Capital, and V3 Ventures. Subtle participation also came from notable investors Aman Gupta (through Shark Tank India) and Namita Thapar (outside the tank). With this round, Go Zero has raised a total of $6 million to date. Earlier in June 2024, Go Zero raised $1.5 million in its follow-on pre-Series A funding round from DSG Consumer Partners, Saama, and V3 Ventures. The proceeds will be used to fuel supply chain expansion, innovation in product offerings, and brand growth as Go Zero continues its expansion on quick-commerce platforms in tier I and tier II markets. Founded by Kiran Shah, Go Zero has a diversified product portfolio featuring low-calorie, high-protein, and vegan ice creams. The startup claims that all its products are sweetened with plant-based sweeteners, which are low in calories. Since its inception in July 2022, Go Zero claims to have offer 100% sugar-free products with 50% fewer calories than traditional ice creams. The brand has achieved 5X revenue growth in its second year and 3X in the third. Despite January being the off-season for ice cream sales, Go Zero recorded its highest-ever sales in January 2025, crossing Rs 5 crore in revenue. With a strong presence across Mumbai, Delhi, Pune, Bangalore, and Hyderabad, Go Zero is also set to launch new guilt-free formats, including kulfi sticks and cassata. The firm currently operates two manufacturing units in Mumbai and Bangalore. Go Zero competes with Hangyo Ice Cream, Hocco, and NIC. In 2023, NIC raised $11 million in a funding round led by Jungle Ventures, while Hocco also secured $12 million from the Chona family and other investors. Meanwhile, Hangyo Ice Cream secured India's largest venture funding for an ice cream brand, raising $25 million from Faering Capital in August last year.

Skincare brand Be Clinical raises seed round led by V3 Ventures

EntrackrEntrackr · 4d ago
Skincare brand Be Clinical raises seed round led by V3 Ventures
Medial

Skincare brand Be Clinical raises seed round led by V3 Ventures Skincare brand Be Clinical has raised Rs 6 crore in a seed funding round led by V3 Ventures, with participation from Titan Capital, founded by Kunal Bahl and Rohit Bansal, who have doubled down on their commitment to the brand. The Mumbai-based brand had previously mopped up Rs 2 crore in the same funding round led by Titan Capital, along with participation from P-TAL founder Aditya Agarwal. The proceeds will be used for research and development to strengthen in-house formulation capabilities, conduct clinical testing, and develop targeted solutions for ageing concerns across the face, body, and scalp, Be Clinical said in a press release. Launched in May last year by Hemangi Dhir, Be Clinical is an evidence-led skincare brand offering clinically tried solutions for ageing skin, developed specifically for Indian skin and conditions. Backed by in-house research and dermatologically active ingredients, the brand addresses ageing concerns with a strong focus on transparency, education, and measurable results. Be Clinical aims to address a gap in the Indian skincare market such as the lack of science-led, transparent, and clinically validated solutions designed specifically for Indian skin and environmental conditions. The brand says that it differentiates itself through in-vivo tested, clinically validated formulations, supported by end-to-end in-house research and manufacturing and responsible formulation. Since its inception, Be Clinical claims that it has demonstrated strong early traction in a short period and served over 25,000 customers, reflecting rapid adoption and growing consumer trust in its clinically driven, India-specific skincare solutions. The company plans to expand its manufacturing facility by adding advanced machinery to improve production capacity, consistency, and quality control. The brand aspires to upgrade packaging with functional, protective, and premium formats that preserve ingredient efficacy while reinforcing the brand’s clinical-grade positioning. It competes with other notable players such as Olay, Neutrogena, Clinique, and Dr. Sheth in the anti-ageing category.

Download the medial app to read full posts, comements and news.